Enterome, a gut healthcare company backed by Natixis venture unit Seventure, raises the funds after a $1.5m seed round from Inra Transfert, the French National Institute in Agronomic Research's tech transfer organisation.

Enterome, a company focused on diseases of the gut, has raised €5m ($6.6m).

The company’s series A was co-led by Seventure, part of France-based bank Natixis, and venture firm Lundbeckfond Ventures.

It previously raised €1.5m from Seventure Partners and Inra Transfert,  the French National Institute in Agronomic Research’s tech transfer organisation.

Gérard Jacquin, president of Inra Technology Transfer organisation, said: "We are particularly pleased to see one of our main research assets being translated into a company and financed by…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?